HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc.
Insider Sentiment (TTM):
Last Purchase:2023-08-21Last Sale:2025-08-19Shares Purchased (TTM):0Shares Sold (TTM):0
Institutional Sentiment:
As of:2025-06-30Institutional Shares Owned:4,233,015Shares Outstanding:12,544,777Institutional Ownership Pct.:33.74%
Earnings Market Reaction:
Filing Date:2025-05-15Price on Filing Date:N/APrevious Close:N/A% Change:N/A
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common Stock Other Than Class | 10 | 10 | 0 | 0 | 10 | 10 | 0 | -44 | 52 | 52 | 1 | 0 | |||||
Series1 Convertible Preferred Stock | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | |||||
Common Class A | 2 | 2 | 0 | 0 | 2 | 2 | 0 | 0 | 2 | 2 | -1 | 0 | |||||
Assets | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 40 | 40 | 60 | 77 | 93 | 117 | 108 | 136 | 110 | 112 | 100 | 118 | |||||
Restricted Cash Current | 0 | 0 | - | - | - | - | - | - | - | 1 | 0 | 1 | |||||
Assets Current | |||||||||||||||||
Accounts Receivable Net Current | 1 | 0 | 0 | 0 | 10 | 1 | 1 | 0 | 1 | 7 | 1 | 1 | |||||
Assets Current | 60 | 81 | 93 | 107 | 133 | 147 | 139 | 168 | 140 | 147 | 130 | 149 | |||||
Assets Held For Sale Not Part Of Disposal Group Cu… | 2 | 2 | - | - | - | - | - | - | - | - | - | - | |||||
Prepaid Expense And Other Assets Current | 9 | 15 | 8 | 8 | - | 11 | - | - | - | - | - | - | |||||
Restricted Cash Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Property Plant And Equipment Net | 0 | 0 | 7 | 7 | 7 | 8 | 20 | 18 | 18 | 18 | 17 | 17 | |||||
Operating Lease Right Of Use Asset | 1 | 1 | 3 | 5 | 5 | 5 | 3 | 3 | 4 | 4 | 4 | 5 | |||||
Assets Noncurrent | |||||||||||||||||
Assets Noncurrent | 1 | 2 | 17 | 18 | 13 | 14 | 25 | 23 | 23 | 23 | 22 | 23 | |||||
Finance Lease Right Of Use Asset | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Other Assets Noncurrent | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Prepaid Expense And Other Assets Noncurrent | 0 | 1 | 7 | 5 | - | 1 | - | - | - | - | - | - | |||||
Assets | 61 | 83 | 110 | 125 | 146 | 161 | 164 | 191 | 163 | 170 | 152 | 172 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Accounts Payable Current | 4 | 9 | 9 | 11 | 11 | 12 | 9 | 12 | 7 | 5 | 8 | 6 | |||||
Deferred Revenue Current | 4 | 5 | 5 | 4 | 5 | 15 | 16 | 20 | 19 | 16 | 8 | 10 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 17 | 25 | 29 | 28 | 30 | 42 | 41 | 46 | 44 | 36 | 26 | 27 | |||||
Operating Lease Liability Current | 0 | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | |||||
Loans Payable Current | - | - | - | - | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | |||||
Loans Payable | - | - | - | - | - | - | - | - | - | 1 | 1 | 1 | |||||
Liabilities Noncurrent | |||||||||||||||||
Liabilities Noncurrent | 11 | 7 | 9 | 11 | 12 | 29 | 28 | 33 | 35 | 32 | 12 | 13 | |||||
Operating Lease Liability Noncurrent | 0 | 0 | 2 | 3 | 3 | 4 | 1 | 2 | 2 | 2 | 2 | 3 | |||||
Deferred Revenue Noncurrent | 1 | 1 | 2 | 2 | 3 | 20 | 24 | 27 | 30 | 26 | 7 | 7 | |||||
Other Liabilities Noncurrent | 10 | 6 | 6 | 6 | 6 | 6 | 3 | 3 | 3 | 3 | 2 | 2 | |||||
Liabilities | 27 | 31 | 38 | 39 | 41 | 71 | 69 | 79 | 80 | 68 | 38 | 40 | |||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 469 | 469 | 468 | 467 | 467 | 467 | 446 | 445 | 398 | 397 | 396 | 395 | |||||
Stockholders Equity | |||||||||||||||||
Stockholders Equity | 34 | 51 | 72 | 86 | 105 | 90 | 95 | 112 | 83 | 103 | 113 | 132 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -6 | -5 | -9 | -7 | -7 | -8 | -6 | -7 | -7 | -7 | -8 | -6 | |||||
Retained Earnings Accumulated Deficit | -428 | -413 | -388 | -374 | -355 | -369 | -344 | -325 | -307 | -288 | -275 | -257 | |||||
Liabilities And Stockholders Equity | 61 | 83 | 110 | 125 | 146 | 161 | 164 | 191 | 163 | 170 | 152 | 172 | |||||
Seriesa Convertible Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | |||||
Seriesa1 Convertible Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | - | |||||
Series A2 Convertible Preferred Stock | 0 | 0 | 0 | -0 | 0 | 0 | -0 | 0 | - | 0 | - | - | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |||||
Common Stock Par Or Stated Value Per Share | - | - | - | 0 | - | - | - | - | - | - | - | - | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
0/5
Search a metric to start building a table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
0/1
Search a metric to start building a visual
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 7.59% | -15.17% | -38.94% | - | - | - | - | - | - | - | - | - |
| 2024 | -0.75% | -26.02% | -23.12% | 3.36% | -16.21% | -25.30% | -20.06% | -40.76% | -37.58% | -18.30% | -49.46% | 1.96% |
| 2023 | -39.89% | -53.19% | -59.20% | -8.62% | -17.34% | -42.30% | 30.71% | 84.13% | 59.31% | 10.60% | 8.00% | 15.17% |
| 2022 | 23.57% | 33.57% | 15.71% | -11.95% | -15.72% | -20.13% | -32.76% | -22.89% | -13.79% | -10.40% | 106.17% | 39.51% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 3.61 | 3.27 | 3.26 | 3.86 | 4.50 | 3.50 | 3.44 | 3.64 | 3.16 | 4.13 | 4.98 | 5.48 | |||||
| Quick Ratio | 3.07 | 2.66 | 2.97 | 3.58 | 4.50 | 3.25 | 3.44 | 3.64 | 3.16 | 4.13 | 4.98 | 5.48 | |||||
| Working Capital | 43.45M | 56.01M | 64.59M | 79.52M | 103.20M | 105.13M | 98.90M | 121.90M | 95.70M | 111.56M | 103.56M | 121.85M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.80 | 0.61 | 0.53 | 0.45 | 0.40 | 0.80 | 0.73 | 0.70 | 0.95 | 0.66 | 0.34 | 0.31 | |||||
| Interest Coverage TTM | -20,108.75 | -8,575.83 | -1,107.11 | -636.44 | -324.52 | -308.18 | -213.80 | -182.20 | -133.68 | -106.48 | -101.26 | -87.47 | |||||
| Debt Ratio | 0.44 | 0.38 | 0.35 | 0.31 | 0.28 | 0.44 | 0.42 | 0.41 | 0.49 | 0.40 | 0.25 | 0.23 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.09 | 0.36 | 0.37 | 0.33 | 0.35 | 0.12 | 0.13 | 0.09 | 0.09 | 0.10 | 0.07 | 0.07 | |||||
| Days Sales Outstanding TTM | 209.94 | 3.33 | 3.65 | 1.18 | 36.51 | 63.86 | 12.59 | 16.54 | 13.75 | 171.98 | 57.73 | 93.23 | |||||
| Receivables Turnover TTM | 1.74 | 109.73 | 100.10 | 309.57 | 10.00 | 5.72 | 28.98 | 22.07 | 26.54 | 2.12 | 6.32 | 3.91 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -5.84 | -3.47 | -3.46 | -3.88 | -3.77 | -8.63 | -6.26 | -8.26 | -9.23 | -9.91 | -10.22 | -10.47 | |||||
| Free Cash Flow Per Share TTM | -4.21 | -6.15 | -5.41 | -6.18 | -6.61 | -6.53 | -3.40 | -3.36 | -3.88 | -3.82 | -7.74 | -8.12 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | - | - | - | - | 100.37% | 101.57% | 101.83% | 102.71% | 103.54% | 104.82% | 107.81% | 107.82% | |||||
| Operating Profit Margin TTM | -860.18% | -117.09% | -121.78% | -124.45% | -119.38% | -485.34% | -391.18% | -494.63% | -473.50% | -513.40% | -791.14% | -683.84% | |||||
| Net Profit Margin TTM | -784.01% | -98.99% | -86.74% | -93.16% | -88.73% | -405.29% | -336.12% | -429.13% | -416.94% | -455.58% | -715.76% | -632.09% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -82.54% | 118.32% | 143.30% | 227.80% | 235.12% | 41.27% | 99.21% | 33.05% | 9.51% | -22.76% | -47.68% | -39.85% | |||||
| Net Income Growth (1Y) | 54.29% | -46.67% | -37.21% | -28.84% | -28.68% | 25.67% | -6.45% | -9.67% | -12.79% | -14.21% | 10.36% | 25.05% | |||||
| EPS Growth (1Y) | 54.21% | -59.80% | -44.72% | -53.06% | -58.92% | -12.90% | -38.79% | -21.15% | -45.61% | -57.00% | -49.77% | -43.18% | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -52.87M | -77.17M | -67.88M | -77.48M | -82.83M | -61.68M | -37.50M | -27.83M | -28.04M | -25.01M | -55.94M | -58.60M | |||||
| Net Debt | -40.48M | -39.89M | -59.96M | -77.35M | -91.81M | -116.40M | -107.07M | -135.00M | -107.95M | -111.85M | -99.28M | -117.44M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
2025-08-19Sale
Owner: Peters, Malte
Title: Chief Executive Officer
Shares: 25,172
Price/Share: $0.82
Value: $20,641.04
Shares Owned: 54,347
Relationship: Director,Officer
Ownership: Direct
2025-07-22Sale
Owner: Peters, Malte
Title: Chief Executive Officer
Shares: 29,176
Price/Share: $0.92
Value: $26,841.92
Shares Owned: 79,519
Relationship: Director,Officer
Ownership: Direct
2025-07-22Sale
Owner: Coelho, Mary Theresa
Title: EVP and CFO
Shares: 13,609
Price/Share: $0.92
Value: $12,520.28
Shares Owned: 56,266
Relationship: Director,Officer
Ownership: Direct
2023-08-21Purchase
Owner: Kandera, Reinhard
Title: Chief Financial Officer
Shares: 7,000
Price/Share: $0.73
Value: $5,110.00
Shares Owned: 43,092
Relationship: Director,Officer
Ownership: Direct
2023-08-16Purchase
Owner: Kandera, Reinhard
Title: Chief Financial Officer
Shares: 8,000
Price/Share: $0.71
Value: $5,680.00
Shares Owned: 36,092
Relationship: Director,Officer
Ownership: Direct
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
No data available for chart
2025-06-30
33.74%
Inst. Shares: 4,233,015
Shares Outstanding: 12,544,777
2025-03-31
34.69%
Inst. Shares: 4,352,088
Shares Outstanding: 12,544,777
2024-12-31
42.07%
Inst. Shares: 5,274,885
Shares Outstanding: 12,538,794
2024-09-30
23.34%
Inst. Shares: 2,926,470
Shares Outstanding: 12,538,774
2024-06-30
20.74%
Inst. Shares: 2,600,016
Shares Outstanding: 12,538,774
HOOKIPA Pharma Inc. (HOOK) — SEC Financial Statements & Analysis
HOOKIPA Pharma Inc. (HOOK) is a pharmaceutical preparations company, incorporated in DE. HOOKIPA Pharma Inc. trades on OTC as: HOOK. Based on its latest SEC filing (Form 10-Q, period ending 2025-03-31), HOOKIPA Pharma Inc. reported a -82.54% year-over-year revenue growth, a Gross Profit Margin of 100.37% (TTM), a Debt-to-Equity ratio of 0.80x. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -82.54%
- Gross Profit Margin TTM
- 100.37%
- Debt To Equity
- 0.80x
Data as of 2025-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is HOOKIPA Pharma Inc. in?
HOOKIPA Pharma Inc. (HOOK) operates in the Pharmaceutical Preparations industry.
What exchange does HOOK trade on?
HOOKIPA Pharma Inc. (HOOK) trades on the OTC.
Where is HOOKIPA Pharma Inc. incorporated?
HOOKIPA Pharma Inc. is incorporated in DE.